Literature DB >> 11680626

Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo.

M Patten1, E Krämer, J Bünemann, C Wenck, M Thoenes, T Wieland, C Long.   

Abstract

Release of bacterial endotoxin and cytokines induce cardiac failure during sepsis. We investigated the direct effects of E. coli endotoxin (lipopolysaccharide, LPS) and cytokines induced by LPS on the cardiac myocyte gene program. For in vivo-experiments adult Wistar rats were given 600 microg/day LPS i.v. for 24 h or 7 days. In addition, cultured adult rat cardiac myocytes were treated with LPS, interleukin-1beta (IL-1beta), tumour necrosis factor-alpha (TNFalpha), interferon-gamma (IFNgamma) or IL-6 for 24 h. mRNA expression was evaluated for cardiac-alpha-actin (cAct), skeletal-alpha-actin (skAct), beta- and alpha-myosin heavy chain (MHC). LPS induced betaMHC-mRNA 3.6-fold and repressed alphaMHC 2.7-fold and cAct 2.5-fold after 24 h in vivo. Up-regulation of betaMHC (3-fold) and repression of cAct (2.5-fold) were still observed after 7 days LPS infusion, whereas alphaMHC-mRNA levels had returned to normal. At the protein level, increased expression of betaMHC by LPS treatment occurred already after 24 h and was maintained thereafter. LPS had no influence on skAct-mRNA. Similar changes in contractile protein mRNA expression were observed in LPS-treated cardiomyocytes in culture, whereas the tested cytokines either activated (IL-1beta, IFNgamma) or repressed (TNFalpha, IL-6) both MHC-isoforms and cAct. In conclusion, LPS and proinflammatory cytokines induce changes in contractile protein expression that may contribute to the acute heart failure observed during endotoxaemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680626     DOI: 10.1007/s004240100612

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  24 in total

1.  Interferon-γ causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis.

Authors:  Pippa F Cosper; Pamela A Harvey; Leslie A Leinwand
Journal:  Am J Pathol       Date:  2012-10-08       Impact factor: 4.307

Review 2.  TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.

Authors:  Petra Kleinbongard; Rainer Schulz; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

3.  The influence of folic acid-induced acute kidney injury on cardiac function and redox status in rats.

Authors:  Tomislav Nikolic; Dejan Petrovic; Stevan Matic; Tamara Nikolic Turnic; Jovana Jeremic; Katarina Radonjic; Ivan Srejovic; Vladimir Zivkovic; Stefani Bolevich; Sergey Bolevich; Vladimir Jakovljevic
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-27       Impact factor: 3.000

Review 4.  Cellular apoptosis in the cardiorenal axis.

Authors:  Grazia Maria Virzì; Anna Clementi; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

Review 5.  Could interferon-gamma be a therapeutic target for treating heart failure?

Authors:  Scott P Levick; Paul H Goldspink
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

6.  HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats.

Authors:  Geeta Datta; Himanshu Gupta; Zhenghao Zhang; Palgunachari Mayakonda; G M Anantharamaiah; C Roger White
Journal:  J Clin Exp Cardiolog       Date:  2011-12-22

7.  Interleukin-1beta mediates endotoxin- and tumor necrosis factor alpha-induced RGS16 protein expression in cultured cardiac myocytes.

Authors:  Monica Patten; Sabine Stübe; Bryan Thoma; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000

8.  Cardiac-specific overexpression of insulin-like growth factor I (IGF-1) rescues lipopolysaccharide-induced cardiac dysfunction and activation of stress signaling in murine cardiomyocytes.

Authors:  Peng Zhao; Subat Turdi; Feng Dong; Xiaoyan Xiao; Guohai Su; Xinglei Zhu; Glenda I Scott; Jun Ren
Journal:  Shock       Date:  2009-07       Impact factor: 3.454

9.  Cardiorenal Syndrome Type 1: Activation of Dual Apoptotic Pathways.

Authors:  Silvia Pastori; Grazia Maria Virzì; Alessandra Brocca; Massimo de Cal; Vincenzo Cantaluppi; Chiara Castellani; Marny Fedrigo; Gaetano Thiene; Maria Luisa Valente; Annalisa Angelini; Giorgio Vescovo; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2015-09-02       Impact factor: 2.041

Review 10.  Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.

Authors:  Erik Tandberg Askevold; Lars Gullestad; Christen P Dahl; Arne Yndestad; Thor Ueland; Pål Aukrust
Journal:  Curr Heart Fail Rep       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.